William F Doyle - Net Worth and Insider Trading

William F Doyle Net Worth

The estimated net worth of William F Doyle is at least $18 Million dollars as of 2024-12-29. William F Doyle is the Executive Chairman of NovoCure Ltd and owns about 551,176 shares of NovoCure Ltd (NVCR) stock worth over $17 Million. William F Doyle is the Director of Elanco Animal Health Inc and owns about 76,330 shares of Elanco Animal Health Inc (ELAN) stock worth over $920,540. William F Doyle is also the Director of Minerva Neurosciences Inc and owns about 3,264 shares of Minerva Neurosciences Inc (NERV) stock worth over $7,377. Details can be seen in William F Doyle's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that William F Doyle has not made any transactions after 2024-05-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of William F Doyle

To

William F Doyle Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, William F Doyle owns 7 companies in total, including NovoCure Ltd (NVCR) , Minerva Neurosciences Inc (NERV) , and OptiNose Inc (OPTN) among others .

Click here to see the complete history of William F Doyle’s form 4 insider trades.

Insider Ownership Summary of William F Doyle

Ticker Comapny Transaction Date Type of Owner
NVCR NovoCure Ltd 2022-08-02 director & 10 percent owner
NERV Minerva Neurosciences Inc 2019-06-27 director
OPTN OptiNose Inc 2017-10-12 director & 10 percent owner
LIMIT LIMIT 2015-02-03 director
LIMIT LIMIT 2024-05-21 director
LIMIT LIMIT 2022-07-11 director
LIMIT LIMIT 2022-07-11 director

William F Doyle Latest Holdings Summary

William F Doyle currently owns a total of 3 stocks. Among these stocks, William F Doyle owns 551,176 shares of NovoCure Ltd (NVCR) as of August 2, 2022, with a value of $17 Million and a weighting of 94.8%. William F Doyle owns 76,330 shares of Elanco Animal Health Inc (ELAN) as of May 21, 2024, with a value of $920,540 and a weighting of 5.16%. William F Doyle also owns 3,264 shares of Minerva Neurosciences Inc (NERV) as of June 27, 2019, with a value of $7,377 and a weighting of 0.04%.

Latest Holdings of William F Doyle

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NVCR NovoCure Ltd 2022-08-02 551,176 30.70 16,921,103
ELAN Elanco Animal Health Inc 2024-05-21 76,330 12.06 920,540
NERV Minerva Neurosciences Inc 2019-06-27 3,264 2.26 7,377

Holding Weightings of William F Doyle


William F Doyle Form 4 Trading Tracker

According to the SEC Form 4 filings, William F Doyle has made a total of 12 transactions in NovoCure Ltd (NVCR) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in NovoCure Ltd is the sale of 837 shares on August 2, 2022, which brought William F Doyle around $58,305.

According to the SEC Form 4 filings, William F Doyle has made a total of 2 transactions in Elanco Animal Health Inc (ELAN) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Elanco Animal Health Inc is the acquisition of 15,000 shares on May 21, 2024, which cost William F Doyle around $254,700.

According to the SEC Form 4 filings, William F Doyle has made a total of 0 transactions in Minerva Neurosciences Inc (NERV) over the past 5 years. The most-recent trade in Minerva Neurosciences Inc is the acquisition of 438 shares on June 27, 2019, which cost William F Doyle around $19,250.

Insider Trading History of William F Doyle

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

William F Doyle Trading Performance

GuruFocus tracks the stock performance after each of William F Doyle's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William F Doyle is -2.31%. GuruFocus also compares William F Doyle's trading performance to market benchmark return within the same time period. The performance of stocks bought by William F Doyle within 3 months outperforms 3 times out of 10 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how William F Doyle's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of William F Doyle

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 8 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -0.55 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -0.22 LIMIT LIMIT LIMIT LIMIT LIMIT

William F Doyle Ownership Network

Ownership Network List of William F Doyle

No Data

Ownership Network Relation of William F Doyle

Insider Network Chart

William F Doyle Owned Company Details

What does NovoCure Ltd do?

Who are the key executives at NovoCure Ltd?

William F Doyle is the director & 10 percent owner of NovoCure Ltd. Other key executives at NovoCure Ltd include President & CNS Cancers US Frank X Leonard , Chief Human Resources Officer Michal Nath Puri , and Chief Financial Officer Ashley Cordova .

NovoCure Ltd (NVCR) Insider Trades Summary

Over the past 18 months, William F Doyle made no insider transaction in NovoCure Ltd (NVCR). Other recent insider transactions involving NovoCure Ltd (NVCR) include a net sale of 5,921 shares made by Wilhelmus Cm Groenhuysen , a net sale of 5,195 shares made by Frank X Leonard , and a net sale of 2,715 shares made by Ashley Cordova .

In summary, during the past 3 months, insiders sold 1,612 shares of NovoCure Ltd (NVCR) in total and bought 0 shares, with a net sale of 1,612 shares. During the past 18 months, 18,392 shares of NovoCure Ltd (NVCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 18,392 shares.

NovoCure Ltd (NVCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NovoCure Ltd Insider Transactions

No Available Data

William F Doyle Mailing Address

Above is the net worth, insider trading, and ownership report for William F Doyle. Currently GuruFocus does not have mailing address information for William F Doyle.

Discussions on William F Doyle

No discussions yet.